EASD 2025 | HighTide Therapeutics Announces Oral Presentation of Phase 3 Data in Patients with Type 2 Diabetes
HONG KONG, Sep 17, 2025 - (ACN...
TruMerit Adds Two More Global Credentials for Rehabilitation Care Workers
PHILADELPHIA, PA, Sept 17, 202...